In case you missed it on July 9, HHS shared this quality fact sheet.

Secretary Azar confirmed the administration’s focus on:

  • Transparency: President Trump’s Executive Order on transparency directs federal agencies to improve price and quality transparency, including streamlining the numerous measurements the federal government uses to track healthcare quality.
  • Outcomes: HHS oversees several quality programs that were initially developed about 20 years ago to strengthen organizational capacity to improve outcomes for beneficiaries.
  • Objective review: These quality programs administered by the Centers for Medicare and Medicaid Services (CMS), Agency for Healthcare Research and Quality (AHRQ), Centers for Disease Control (CDC), Health Resources and Services Administration (HRSA) and Indian Health Service (IHS), have not undergone a systematic objective review to ensure they are serving their stated purpose of improving processes and enhancing communication to improve beneficiary outcomes.
  • Measurement gaps: Internal and external stakeholders have identified gaps between the different quality measures that weaken overall program integrity.

At DataLink, we are staying close to the policy shift and measurement review so we can continue to update and innovate our point-of-care experience and payer and MSO performance management landscape.